<DOC>
	<DOCNO>NCT01773278</DOCNO>
	<brief_summary>Patients biochemically confirm SLOS treat cholesterol supplementation antioxidant medication . They carefully monitor visit clinic , laboratory test include cholesterol 7-dehydrocholesterol level , vitamin level , blood count liver kidney function . On annual basis , patient undergo series test anesthesia , include electroretinogram ( ERG ) , brainstem audiometry ( ABR ) , ophthalmologic exam anesthesia follow pigmentary retinopathy .</brief_summary>
	<brief_title>Cholesterol Antioxidant Treatment Patients With Smith-Lemli-Opitz Syndrome ( SLOS )</brief_title>
	<detailed_description>Smith-Lemli-Opitz Syndrome ( SLOS ) autosomal recessive disorder cause metabolic error final step cholesterol biosynthesis , lead cholesterol deficiency accumulation cholesterol precursor , 7-dehydrocholesterol.Patients SLOS display complex medical problem include growth failure , intellectual disability , behavioral disorder , progressive retinal dystrophy , hear loss photosensitivity . Dr Elias one original geneticist discover cause disorder 1994 , ever since treat SLOS patient cholesterol supplementation . Since 2008 , second medication call AquADEKS , mixture vitamin compound antioxidant property add treatment regimen . The purpose AquADEKS allow treatment antioxidant medication effort prevent retinal degeneration , hear skin problem associate SLOS . This protocol approve Colorado Multiple Institutional Review Board support Clinical Translational Research Center ( CTRC ) since 2001 . Since last Colorado Multiple Institutional Review Board annual review , follow updated information available protocol : 1 . New research reveal oxysterols toxic compound make cholesterol precursor , 7-dehydrocholesterol . These oxysterol compound severely neurotoxic treatment antioxidant may help low level , result slow retinal deterioration . Testing oxysterol level patient SLOS ongoing , collaboration laboratory Vanderbilt University ( Dr Ned Porter ) . It hop test oxysterol level blood may help provide updated info help guide treatment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Clinical diagnosis SmithLemliOpitz Syndrome Elevated level 7dehydrocholesterol 8dehydrocholesterol Must able travel Children 's Hospital Colorado annually Must insurance coverage ERG/ABR study absence detectable 7dehydrocholesterol/8dehydrocholesterol allergy Antioxidant medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Antioxidant treatment</keyword>
	<keyword>Oxysterols</keyword>
	<keyword>Cholesterol deficiency</keyword>
	<keyword>Accumulation 7-dehydrocholesterol</keyword>
	<keyword>electroretinogram ( ERG )</keyword>
	<keyword>Auditory Brainstem Response ( ABR )</keyword>
</DOC>